Cancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution
Open accessThe DOI matches its Crossref record; 221 of the 222 references it cites were found in a registry or an index.
Abstract
The presence and role of microbes in human cancers has come full circle in the last century. Tumors are no longer considered aseptic, but implications for cancer biology and oncology remain underappreciated. Opportunities to identify and build translational diagnostics, prognostics, and therapeutics that exploit cancer's second genome—the metagenome—are manifold, but require careful consideration of microbial experimental idiosyncrasies that are distinct from host‐centric methods. Furthermore, the discoveries of intracellular and intra‐metastatic cancer bacteria necessitate fundamental changes in describing clonal evolution and selection, reflecting bidirectional interactions with non‐human residents. Reconsidering cancer clonality as a multispecies process similarly holds key implications for understanding metastasis and prognosing therapeutic resistance while providing rational guidance for the next generation of bacterial cancer therapies. Guided by these new findings and challenges, this Review describes opportunities to exploit cancer's metagenome in oncology and proposes an evolutionary framework as a first step towards modeling multispecies cancer clonality. Also see the video abstract here: https://youtu.be/-WDtIRJYZSs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Quantitative PCR has estimated that among seven cancer types, approximately 0.68% (95% CI: 0.75, 1.46%) of the tumor cellular content is bacterial, with melanoma-specific density estimates at ~33 bacteria/mm2 or ~6.3×106 bacteria/cm3 on average (using bootstrapped values).”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [127]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Poore, G. D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J., Song, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2095-1 · Cited by 989
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887 · cited 1×
“ing a third revision of the classic cancer “hallmarks” to include “polymorphic microbiomes” of the gut and tumors.[70]”
BackgroundHuman gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Self-citationNowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425 · cited 3×
“Toward building a microbially-conscious framework of cancer, we posit cancer-bearing humans as meta-organisms colonized by numerous, diverse microbial constituents (Box 1).[71,72] We propose the clinical utility of microbial information as cancer diagnostics, prognostics, and therapeutics and consider (intracellular)…”
BackgroundCancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Davis, N. M., Proctor, D. M., Holmes, S. P., Relman, D. A., & Callahan, B. J. (2018) · Microbiome · doi:10.1186/s40168-018-0605-2 · Cited by 3,493
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses
Salter, S. J., Cox, M. J., Turek, E. M., Calus, S. T., Cookson, W. O., Moffatt, M. F., Turner, P., Parkhill, J., Loman, N. J., & Walker, A. W. (2014) · BMC Biology · doi:10.1186/s12915-014-0087-z · Cited by 3,463
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Clonal heterogeneity and tumor evolution: past, present, and the future
McGranahan, N., & Swanton, C. (2017) · Cell · doi:10.1016/j.cell.2017.01.018 · Cited by 2,840 · cited 3×
“Upper figure subpanels depict supported and hypothesizedmicrobial counterparts to the host-specific clonal selectionmodes, mechanisms, and ecosystems originally described byMcGranahan and Swanton.”
BackgroundStructure and function of the global topsoil microbiome
Bahram, M., Hildebrand, F., Forslund, S. K., Anderson, J. L., Soudzilovskaia, N. A., Bodegom, P. M., Bengtsson-Palme, J., Anslan, S., Coelho, L. P., Harend, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0386-6 · Cited by 2,538
Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464
Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis
Johnson, J. S., Spakowicz, D. J., Hong, B.-Y., Petersen, L. M., Demkowicz, P., Chen, L., Leopold, S. R., Hanson, B. M., Agresta, H. O., Gerstein, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13036-1 · Cited by 2,260
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198 · cited 1×
“Research demonstrating effects of extracellular and intracellular microbes on cancer cells’ genomes,[85,139] transcriptomes,[48,50,51,140] proteomes,[49] andmetabolomes[47,65] strongly justifymicrobial inclu-”
BackgroundAnalysis of compositions of microbiomes with bias correction
Lin, H., & Peddada, S. D. (2020) · Nature Communications · doi:10.1038/s41467-020-17041-7 · Cited by 2,104
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050 · cited 2×
“[49,57] Efficacies and toxicities of cyclophosphamide,[66,101] gemcitabine,[47] and platinum-based[67,102]”
BackgroundAre We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Phylogenetic Classification and the Universal Tree
Doolittle, W. F. (1999) · Science · doi:10.1126/science.284.5423.2124 · Cited by 1,888
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The TRACERx consortium, Abbosh, C., The PEACE consortium, Birkbak, N. J., Wilson, G. A., Jamal-Hanjani, M., Constantin, T., Salari, R., Le Quesne, J., Moore, D. A., et al. (2017) · Nature · doi:10.1038/nature22364 · Cited by 1,874
Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., et al. (2017) · Science · doi:10.1126/science.aah5043 · Cited by 1,817
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Davar, D., Dzutsev, A. K., McCulloch, J. A., Rodrigues, R. R., Chauvin, J.-M., Morrison, R. M., Deblasio, R. N., Menna, C., Ding, Q., Pagliano, O., et al. (2021) · Science · doi:10.1126/science.abf3363 · Cited by 1,781
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Baruch, E. N., Youngster, I., Ben-Betzalel, G., Ortenberg, R., Lahat, A., Katz, L., Adler, K., Dick-Necula, D., Raskin, S., Bloch, N., et al. (2021) · Science · doi:10.1126/science.abb5920 · Cited by 1,757
Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., Lai, Z., Markovets, A., Vivancos, A., Kuang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3854 · Cited by 1,589
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Riquelme, E., Zhang, Y., Zhang, L., Montiel, M., Zoltan, M., Dong, W., Quesada, P., Sahin, I., Chandra, V., San Lucas, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.008 · Cited by 1,577
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508 · cited 1×
“modify immunosurveillance also impact when and where tumors grow and/or metastasize.[49,53,54,61,62,142] As distinct agents from cancer”
BackgroundGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Genome-wide cell-free DNA fragmentation in patients with cancer
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1272-6 · Cited by 1,476 · cited 3×
“microbial DNA in plasma, as shown in fragmentomic-based liquid biopsies.[76]”
BackgroundInfluentialDurable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML
DiNardo, C. D., Stein, E. M., de Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Swords, R., Collins, R. H., Mannis, G. N., Pollyea, D. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716984 · Cited by 1,454
Yachida, S., Mizutani, S., Shiroma, H., Shiba, S., Nakajima, T., Sakamoto, T., Watanabe, H., Masuda, K., Nishimoto, Y., Kubo, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0458-7 · Cited by 1,429
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Pushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., Mohan, N., Aykut, B., Usyk, M., Torres, L. E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1134 · Cited by 1,400 · cited 2×
“[153] Pancreatic cancer bacteria induce innate and adaptive immune suppression, including via selective Toll-like receptor ligation leading to Tcell anergy.[48] Conversely, a metastatic melanoma study elucidated”
BackgroundThe Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392
Wirbel, J., Pyl, P. T., Kartal, E., Zych, K., Kashani, A., Milanese, A., Fleck, J. S., Voigt, A. Y., Palleja, A., Ponnudurai, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0406-6 · Cited by 1,373
A unified catalog of 204,938 reference genomes from the human gut microbiome
Almeida, A., Nayfach, S., Boland, M., Strozzi, F., Beracochea, M., Shi, Z. J., Pollard, K. S., Sakharova, E., Parks, D. H., Hugenholtz, P., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0603-3 · Cited by 1,367 · cited 2×
“These cancer genomics conclusions suggest the diversity of the intratumoral microbiome (≥500 unique bacterial species)[57] and gut microbiome (∼4 × 103 bacterial species)[77] substantiate microbiomefocused cancer diagnostics, even if all individual microbes are rare or lowly abundant.”
BackgroundThe microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
Self-citationDNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321
Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
Byndloss, M. X., Olsan, E. E., Rivera-Chávez, F., Tiffany, C. R., Cevallos, S. A., Lokken, K. L., Torres, T. P., Byndloss, A. J., Faber, F., Gao, Y., et al. (2017) · Science · doi:10.1126/science.aam9949 · Cited by 1,215
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H. M., Nomburg, J., Gurjao, C., Manders, F., Dalmasso, G., Stege, P. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2080-8 · Cited by 1,208
Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations
Eisenhofer, R., Minich, J. J., Marotz, C., Cooper, A., Knight, R., & Weyrich, L. S. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.11.003 · Cited by 1,146
Self-citationPatients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
COLEY, W. B. (1893) · The American Journal of the Medical Sciences · doi:10.1097/00000441-189305000-00001 · Cited by 995
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970
COLEY, W. B. (1991) · PubMed · Cited by 965
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Jin, C., Lagoudas, G. K., Zhao, C., Bullman, S., Bhutkar, A., Hu, B., Ameh, S., Sandel, D., Liang, X. S., Mazzilli, S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.040 · Cited by 964 · cited 1×
“Research demonstrating effects of extracellular and intracellular microbes on cancer cells’ genomes,[85,139] transcriptomes,[48,50,51,140] proteomes,[49] andmetabolomes[47,65] strongly justifymicrobial inclu-”
BackgroundPhage diversity, genomics and phylogeny
Dion, M. B., Oechslin, F., & Moineau, S. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0311-5 · Cited by 960
A Basic Guide to Real Time PCR in Microbial Diagnostics: Definitions, Parameters, and Everything
Kralik, P., & Ricchi, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00108 · Cited by 927 · cited 1×
“[125] qPCR[126] and microarrays[127] are “post-extraction” but limited by genomic region-specificity, fragment size, and practical multiplexing.”
BackgroundDaillère, R., Vétizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., Duong, C. P. M., Flament, C., Lepage, P., Roberti, M. P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.009 · Cited by 897
Regional variation limits applications of healthy gut microbiome reference ranges and disease models
He, Y., Wu, W., Zheng, H.-M., Li, P., McDonald, D., Sheng, H.-F., Chen, M.-X., Chen, Z.-H., Ji, G.-Y., Zheng, Z.-D.-X., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0164-x · Cited by 894
Self-citationAbed, J., Emgård, J. E. M., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.006 · Cited by 888 · cited 1×
“Additionally, although cf-mbDNA’s origins remain unknown, possible sources include oral, gut, and intratumoral microbiomes.[53,61,62,91,92]”
BackgroundPatterns of somatic structural variation in human cancer genomes
Li, Y., Roberts, N. D., Wala, J. A., Shapira, O., Schumacher, S. E., Kumar, K., Khurana, E., Waszak, S., Korbel, J. O., Haber, J. E., et al. (2020) · Nature · doi:10.1038/s41586-019-1913-9 · Cited by 867
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
Turner, K. M., Deshpande, V., Beyter, D., Koga, T., Rusert, J., Lee, C., Li, B., Arden, K., Ren, B., Nathanson, D. A., et al. (2017) · Nature · doi:10.1038/nature21356 · Cited by 847
Current status and applications of genome-scale metabolic models
Gu, C., Kim, G. B., Kim, W. J., Kim, H. U., & Lee, S. Y. (2019) · Genome Biology · doi:10.1186/s13059-019-1730-3 · Cited by 785
Synchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aar6918 · Cited by 777
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Peled, J. U., Gomes, A. L. C., Devlin, S. M., Littmann, E. R., Taur, Y., Sung, A. D., Weber, D., Hashimoto, D., Slingerland, A. E., Slingerland, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900623 · Cited by 765
Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment
Anderson, A. R. A., Weaver, A. M., Cummings, P. T., & Quaranta, V. (2006) · Cell · doi:10.1016/j.cell.2006.09.042 · Cited by 754
Expression of a Bacterial Gene in Mammalian Cells
Mulligan, R. C., & Berg, P. (1980) · Science · doi:10.1126/science.6251549 · Cited by 738
Parhi, L., Alon-Maimon, T., Sol, A., Nejman, D., Shhadeh, A., Fainsod-Levi, T., Yajuk, O., Isaacson, B., Abed, J., Maalouf, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16967-2 · Cited by 716 · cited 3×
“Additionally, although cf-mbDNA’s origins remain unknown, possible sources include oral, gut, and intratumoral microbiomes.[53,61,62,91,92]”
BackgroundComprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Cortés-Ciriano, I., Lee, J. J.-K., Xi, R., Jain, D., Jung, Y. L., Yang, L., Gordenin, D., Klimczak, L. J., Zhang, C.-Z., Pellman, D. S., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0576-7 · Cited by 712
Deschasaux, M., Bouter, K. E., Prodan, A., Levin, E., Groen, A. K., Herrema, H., Tremaroli, V., Bakker, G. J., Attaye, I., Pinto-Sietsma, S.-J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0160-1 · Cited by 695
Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection
Charalampous, T., Kay, G. L., Richardson, H., Aydin, A., Baldan, R., Jeanes, C., Rae, D., Grundy, S., Turner, D. J., Wain, J., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0156-5 · Cited by 681
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669
Circular ecDNA promotes accessible chromatin and high oncogene expression
Wu, S., Turner, K. M., Nguyen, N., Raviram, R., Erb, M., Santini, J., Luebeck, J., Rajkumar, U., Diao, Y., Li, B., et al. (2019) · Nature · doi:10.1038/s41586-019-1763-5 · Cited by 667
Goss, G., Tsai, C.-M., Shepherd, F. A., Bazhenova, L., Lee, J. S., Chang, G.-C., Crino, L., Satouchi, M., Chu, Q., Hida, T., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30508-3 · Cited by 645
Non-genetic mechanisms of therapeutic resistance in cancer
Marine, J.-C., Dawson, S.-J., & Dawson, M. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00302-4 · Cited by 635
Establishing microbial composition measurement standards with reference frames
Morton, J. T., Marotz, C., Washburne, A., Silverman, J., Zaramela, L. S., Edlund, A., Zengler, K., & Knight, R. (2019) · Nature Communications · doi:10.1038/s41467-019-10656-5 · Cited by 613
Self-citationMicrobiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Lam, K. C., Araya, R. E., Huang, A., Chen, Q., Di Modica, M., Rodrigues, R. R., Lopès, A., Johnson, S. B., Schwarz, B., Bohrnsen, E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.019 · Cited by 604
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Rheinbay, E., Nielsen, M. M., Abascal, F., Wala, J. A., Shapira, O., Tiao, G., Hornshøj, H., Hess, J. M., Juul, R. I., Lin, Z., et al. (2020) · Nature · doi:10.1038/s41586-020-1965-x · Cited by 602
Erdag, G., Schaefer, J. T., Smolkin, M. E., Deacon, D. H., Shea, S. M., Dengel, L. T., Patterson, J. W., & Slingluff, C. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3218 · Cited by 590 · cited 1×
“1,980) per mm2 in metastatic melanoma,[191] it can be inferred directly from circle packing theory.”
BackgroundKim, H., Nguyen, N.-P., Turner, K., Wu, S., Gujar, A. D., Luebeck, J., Liu, J., Deshpande, V., Rajkumar, U., Namburi, S., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0678-2 · Cited by 589
The Microbiome Quality Control Project Consortium, Sinha, R., Abu-Ali, G., Vogtmann, E., Fodor, A. A., Ren, B., Amir, A., Schwager, E., Crabtree, J., Ma, S., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3981 · Cited by 587
Self-citationPattern pluralism and the Tree of Life hypothesis
Doolittle, W. F., & Bapteste, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610699104 · Cited by 546
Association of Streptococcus bovis with Carcinoma of the Colon
Klein, R. S., Recco, R. A., Catalano, M. T., Edberg, S. C., Casey, J. I., & Steigbigel, N. H. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710132971503 · Cited by 532
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
(2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw029 · Cited by 523 · cited 1×
“Estrogen-receptor-positive breast cancer may be affected by microbial hormone metabolism,[105,106]”
BackgroundBertocchi, A., Carloni, S., Ravenda, P. S., Bertalot, G., Spadoni, I., Lo Cascio, A., Gandini, S., Lizier, M., Braga, D., Asnicar, F., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.004 · Cited by 515 · cited 3×
“Additionally, although cf-mbDNA’s origins remain unknown, possible sources include oral, gut, and intratumoral microbiomes.[53,61,62,91,92]”
BackgroundPrimer, Pipelines, Parameters: Issues in 16S rRNA Gene Sequencing
Abellan-Schneyder, I., Matchado, M. S., Reitmeier, S., Sommer, A., Sewald, Z., Baumbach, J., List, M., & Neuhaus, K. (2021) · mSphere · doi:10.1128/msphere.01202-20 · Cited by 498 · cited 1×
“, viruses, archaea) measured by the shotgun read approach; (ii) technical amplification biases of the V6 region may under-represent certain bacteria, with a recent in silico study showing ∼55% of bacteria being inadequately covered by V6V8 primers;[190] and (iii) the qPCR data were normalized to non-template contamina…”
MethodIdentification of bacteria-derived HLA-bound peptides in melanoma
Kalaora, S., Nagler, A., Nejman, D., Alon, M., Barbolin, C., Barnea, E., Ketelaars, S. L. C., Cheng, K., Vervier, K., Shental, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03368-8 · Cited by 457
PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems
Ghaffarizadeh, A., Heiland, R., Friedman, S. H., Mumenthaler, S. M., & Macklin, P. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005991 · Cited by 451
Dr William Coley and tumour regression: a place in history or in the future
Hoption Cann, S. A., van Netten, J. P., & van Netten, C. (2003) · Postgraduate Medical Journal · doi:10.1093/postgradmedj/79.938.672 · Cited by 433
Karst, S. M., Ziels, R. M., Kirkegaard, R. H., Sørensen, E. A., McDonald, D., Zhu, Q., Knight, R., & Albertsen, M. (2021) · Nature Methods · doi:10.1038/s41592-020-01041-y · Cited by 423
Self-citationQuantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome
Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., de Wouters, T., Juste, C., Rizkalla, S., Chilloux, J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.001 · Cited by 420
Basic Concepts of Microarrays and Potential Applications in Clinical Microbiology
Miller, M. B., & Tang, Y.-W. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-09 · Cited by 419
Tomasetti, C., Vogelstein, B., & Parmigiani, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221068110 · Cited by 414
Global diversity of microbial communities in marine sediment
Hoshino, T., Doi, H., Uramoto, G.-I., Wörmer, L., Adhikari, R. R., Xiao, N., Morono, Y., D’Hondt, S., Hinrichs, K.-U., & Inagaki, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919139117 · Cited by 412
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
Shi, Y., Zheng, W., Yang, K., Harris, K. G., Ni, K., Xue, L., Lin, W., Chang, E. B., Weichselbaum, R. R., & Fu, Y.-X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192282 · Cited by 409
Genetic Progression and the Waiting Time to Cancer
Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., & Nowak, M. A. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030225 · Cited by 408
Readfish enables targeted nanopore sequencing of gigabase-sized genomes
Payne, A., Holmes, N., Clarke, T., Munro, R., Debebe, B. J., & Loose, M. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00746-x · Cited by 408
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host
Meisel, M., Hinterleitner, R., Pacis, A., Chen, L., Earley, Z. M., Mayassi, T., Pierre, J. F., Ernest, J. D., Galipeau, H. J., Thuille, N., et al. (2018) · Nature · doi:10.1038/s41586-018-0125-z · Cited by 406 · cited 2×
“[85] Meisel et al. demonstrated in preclinical mouse mod- els that gut microbial translocation to systemic circulation with resul- tant IL-6productiondrives conversion frompredisposingTet2germline mutations to PMP.[86] Nené et al. reported significant cervicovaginal microbiome changes (absence of Lactobacillus species…”
BackgroundCross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., et al. (2020) · Science · doi:10.1126/science.aax0701 · Cited by 396 · cited 1×
“MIDS also includes mimicry between microbial and cancer antigens.[156,157] Should genetic cargo be shared between intracellular bacteria and host cells, as biotechnology already shows is possible[24] and cancer virology affirms,[45,46] MIDS must account for DNA and”
BackgroundOral Somatic Transgene Vaccination Using Attenuated S. typhimurium
Darji, A., Guzmán, C. A., Gerstel, B., Wachholz, P., Timmis, K. N., Wehland, J., Chakraborty, T., & Weiss, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80465-1 · Cited by 396
Genomic basis for RNA alterations in cancer
PCAWG Transcriptome Core Group, Calabrese, C., Davidson, N. R., Demircioğlu, D., Fonseca, N. A., He, Y., Kahles, A., Lehmann, K.-V., Liu, F., Shiraishi, Y., et al. (2020) · Nature · doi:10.1038/s41586-020-1970-0 · Cited by 393
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Li, S., Garrett-Bakelman, F. E., Chung, S. S., Sanders, M. A., Hricik, T., Rapaport, F., Patel, J., Dillon, R., Vijay, P., Brown, A. L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4125 · Cited by 387
Helicobacter pylori evolution and phenotypic diversification in a changing host
Suerbaum, S., & Josenhans, C. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1658 · Cited by 384 · cited 4×
“Helicobacter pylori is a well-studied example of microbial effects on the TME,[163] and has adapted to thrive in the majority of humans long enough to trace migration events.[164] H.”
BackgroundInfluentialCompartmentalized and systemic control of tissue immunity by commensals
Belkaid, Y., & Naik, S. (2013) · Nature Immunology · doi:10.1038/ni.2604 · Cited by 382 · cited 1×
“Toward building a microbially-conscious framework of cancer, we posit cancer-bearing humans as meta-organisms colonized by numerous, diverse microbial constituents (Box 1).[71,72] We propose the clinical utility of microbial information as cancer diagnostics, prognostics, and therapeutics and consider (intracellular)…”
BackgroundThe landscape of viral associations in human cancers
Zapatka, M., Borozan, I., Brewer, D. S., Iskar, M., Grundhoff, A., Alawi, M., Desai, N., Sültmann, H., Moch, H., Pathogens, P., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0558-9 · Cited by 382
Roboz, G. J., DiNardo, C. D., Stein, E. M., de Botton, S., Mims, A. S., Prince, G. T., Altman, J. K., Arellano, M. L., Donnellan, W., Erba, H. P., et al. (2020) · Blood · doi:10.1182/blood.2019002140 · Cited by 381
Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
Nam, A. S., Chaligne, R., & Landau, D. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-0265-5 · Cited by 378
Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
Griffin, M. E., Espinosa, J., Becker, J. L., Luo, J.-D., Carroll, T. S., Jha, J. K., Fanger, G. R., & Hang, H. C. (2021) · Science · doi:10.1126/science.abc9113 · Cited by 366
Gu, W., Crawford, E. D., O’Donovan, B. D., Wilson, M. R., Chow, E. D., Retallack, H., & DeRisi, J. L. (2016) · Genome Biology · doi:10.1186/s13059-016-0904-5 · Cited by 358
Exploring the landscape of focal amplifications in cancer using AmpliconArchitect
Deshpande, V., Luebeck, J., Nguyen, N.-P. D., Bakhtiari, M., Turner, K. M., Schwab, R., Carter, H., Mischel, P. S., & Bafna, V. (2019) · Nature Communications · doi:10.1038/s41467-018-08200-y · Cited by 356
Tumor metabolism: cancer cells give and take lactate
Semenza, G. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37373 · Cited by 351
Improving saliva shotgun metagenomics by chemical host DNA depletion
Marotz, C. A., Sanders, J. G., Zuniga, C., Zaramela, L. S., Knight, R., & Zengler, K. (2018) · Microbiome · doi:10.1186/s40168-018-0426-3 · Cited by 347
Self-citationAnalysis of microbial compositions: a review of normalization and differential abundance analysis
Lin, H., & Peddada, S. D. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-00160-w · Cited by 341
Does the cell number 109still really fit one gram of tumor tissue?
Del Monte, U. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7608 · Cited by 330
Extrachromosomal oncogene amplification in tumour pathogenesis and evolution
Verhaak, R. G. W., Bafna, V., & Mischel, P. S. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0128-6 · Cited by 329
Casasanta, M. A., Yoo, C. C., Udayasuryan, B., Sanders, B. E., Umaña, A., Zhang, Y., Peng, H., Duncan, A. J., Wang, Y., Li, L., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9157 · Cited by 327 · cited 3×
“[3,11,141] Intracellular localization of metabolically active, immunogenic cancer microbes that shape cancer immunoediting—evolutionary processes and selection pressures previously privileged to cancer clonal selection—also provides justification.[49,57,63] Identification of hybrid microbial-human reads involved in ca…”
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
Pernigoni, N., Zagato, E., Calcinotto, A., Troiani, M., Mestre, R. P., Calì, B., Attanasio, G., Troisi, J., Minini, M., Mosole, S., et al. (2021) · Science · doi:10.1126/science.abf8403 · Cited by 323 · cited 4×
“Genetic clonal evolution also fails to account for microbialmediated treatment efficacy or failure of (i) cyclophosphamide,[66,101] gemcitabine,[47] and platinum-based[67,102] chemotherapy; (ii) antiCTLA-4 and anti-PD-(L)1 ICB efficacy[12–14,96–100]; (iii) androgen deprivation therapy in prostate cancer[65]; and (iv)…”
BackgroundInfluentialLower Airway Dysbiosis Affects Lung Cancer Progression
Tsay, J.-C. J., Wu, B. G., Sulaiman, I., Gershner, K., Schluger, R., Li, Y., Yie, T.-A., Meyn, P., Olsen, E., Perez, L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0263 · Cited by 322
Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis
Islami, F., & Kamangar, F. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0109 · Cited by 320 · cited 1×
“protective and pathogenic roles: protective against gastric cardia and esophageal adenocarcinoma[165,166] andpathogenic in noncardiac gastric cancer.”
BackgroundThe evolution of tumour phylogenetics: principles and practice
Schwartz, R., & Schäffer, A. A. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.170 · Cited by 318
Cervicovaginal microbiome and natural history of HPV in a longitudinal study
Usyk, M., Zolnik, C. P., Castle, P. E., Porras, C., Herrero, R., Gradissimo, A., Gonzalez, P., Safaeian, M., Schiffman, M., Burk, R. D., et al. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008376 · Cited by 313
Genetic and non-genetic clonal diversity in cancer evolution
Black, J. R. M., & McGranahan, N. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00336-2 · Cited by 292
Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization
Sizemore, D. R., Branstrom, A. A., & Sadoff, J. C. (1995) · Science · doi:10.1126/science.270.5234.299 · Cited by 285
Starnes, C. O. (1992) · Nature · doi:10.1038/357011a0 · Cited by 284
Topography of cancer-associated immune cells in human solid tumors
Kather, J. N., Suarez-Carmona, M., Charoentong, P., Weis, C.-A., Hirsch, D., Bankhead, P., Horning, M., Ferber, D., Kel, I., Herpel, E., et al. (2018) · eLife · doi:10.7554/elife.36967 · Cited by 280
Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer
Kwong, T. N. Y., Wang, X., Nakatsu, G., Chow, T. C., Tipoe, T., Dai, R. Z. W., Tsoi, K. K. K., Wong, M. C. S., Tse, G., Chan, M. T. V., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.028 · Cited by 280
Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
Robertson-Tessi, M., Gillies, R. J., Gatenby, R. A., & Anderson, A. R. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1428 · Cited by 279
Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy
Shiao, S. L., Kershaw, K. M., Limon, J. J., You, S., Yoon, J., Ko, E. Y., Guarnerio, J., Potdar, A. A., McGovern, D. P. B., Bose, S., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.002 · Cited by 275
Le Noci, V., Guglielmetti, S., Arioli, S., Camisaschi, C., Bianchi, F., Sommariva, M., Storti, C., Triulzi, T., Castelli, C., Balsari, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.090 · Cited by 270
Abed, J., Maalouf, N., Manson, A. L., Earl, A. M., Parhi, L., Emgård, J. E. M., Klutstein, M., Tayeb, S., Almogy, G., Atlan, K. A., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00400 · Cited by 267
Combining 16S rRNA gene variable regions enables high-resolution microbial community profiling
(2017) · doi:10.1186/s40168-017-0396-x · Cited by 266
Quantification of subclonal selection in cancer from bulk sequencing data
Williams, M. J., Werner, B., Heide, T., Curtis, C., Barnes, C. P., Sottoriva, A., & Graham, T. A. (2018) · Nature Genetics · doi:10.1038/s41588-018-0128-6 · Cited by 261
Mazor, T., Pankov, A., Johnson, B. E., Hong, C., Hamilton, E. G., Bell, R. J. A., Smirnov, I. V., Reis, G. F., Phillips, J. J., Barnes, M. J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.012 · Cited by 258
Shlomi, T., Benyamini, T., Gottlieb, E., Sharan, R., & Ruppin, E. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002018 · Cited by 244
Introduction to Circle Packing: The Theory of Discrete Analytic Functions
Stephenson, K. (2005) · Cited by 240
A Turning Point in Cancer Research: Sequencing the Human Genome
Dulbecco, R. (1986) · Science · doi:10.1126/science.3945817 · Cited by 235
Defining HPV-specific B cell responses in patients with head and neck cancer
Wieland, A., Patel, M. R., Cardenas, M. A., Eberhardt, C. S., Hudson, W. H., Obeng, R. C., Griffith, C. C., Wang, X., Chen, Z. G., Kissick, H. T., et al. (2021) · Nature · doi:10.1038/s41586-020-2931-3 · Cited by 232
The gut microbiota in conventional and serrated precursors of colorectal cancer
Peters, B. A., Dominianni, C., Shapiro, J. A., Church, T. R., Wu, J., Miller, G., Yuen, E., Freiman, H., Lustbader, I., Salik, J., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0218-6 · Cited by 230
Functional gene transfer from intracellular bacteria to mammalian cells
Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D. M., & Courvalin, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-862 · Cited by 230
Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms
White, M. K., Pagano, J. S., & Khalili, K. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00124-13 · Cited by 228
The Papyrus Ebers; The Greatest Egyptian Medical Document
Dawson, W. R., & Ebbell, B. (1938) · The Journal of Egyptian Archaeology · doi:10.2307/3854804 · Cited by 224
Merlevede, J., Droin, N., Qin, T., Meldi, K., Yoshida, K., Morabito, M., Chautard, E., Auboeuf, D., Fenaux, P., Braun, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms10767 · Cited by 219
Oxygen and the Spatial Structure of Microbial Communities
Fenchel, T., & Finlay, B. (2008) · Biological Reviews · doi:10.1111/j.1469-185x.2008.00054.x · Cited by 216 · cited 1×
“[168–170] Common selection pressures may drive common evolutionary solutions, such as metabolic symbiosis between cancer cells[171] or between microbes positioned along an oxygen gradient.[170] pH gradients are tied to oxygen and common in tumors,[167] and shape microbial compositions in environmental contexts.”
BackgroundA Method for Selectively Enriching Microbial DNA from Contaminating Vertebrate Host DNA
Feehery, G. R., Yigit, E., Oyola, S. O., Langhorst, B. W., Schmidt, V. T., Stewart, F. J., Dimalanta, E. T., Amaral-Zettler, L. A., Davis, T., Quail, M. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076096 · Cited by 212
A mathematical model of ctDNA shedding predicts tumor detection size
Avanzini, S., Kurtz, D. M., Chabon, J. J., Moding, E. J., Hori, S. S., Gambhir, S. S., Alizadeh, A. A., Diehn, M., & Reiter, J. G. (2020) · Science Advances · doi:10.1126/sciadv.abc4308 · Cited by 208
Kowarsky, M., Camunas-Soler, J., Kertesz, M., De Vlaminck, I., Koh, W., Pan, W., Martin, L., Neff, N. F., Okamoto, J., Wong, R. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707009114 · Cited by 200 · cited 3×
“, bacterial, viral, fungal, eukaryotic pathogens) microbial databases, suggesting that cell-free DNA from hundreds of previously uncharacterized bacteria and viruses existed in human plasma, several of which were validated by orthogonal analyses.[90] Future character-”
BackgroundInfluentialClonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Quek, L., David, M. D., Kennedy, A., Metzner, M., Amatangelo, M., Shih, A., Stoilova, B., Quivoron, C., Heiblig, M., Willekens, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0115-6 · Cited by 200
Modelling approaches for studying the microbiome
Kumar, M., Ji, B., Zengler, K., & Nielsen, J. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0491-9 · Cited by 193
Retention of leukocytes in capillaries: role of cell size and deformability
Downey, G. P., Doherty, D. E., Schwab, B., Elson, E. L., Henson, P. M., & Worthen, G. S. (1990) · Journal of Applied Physiology · doi:10.1152/jappl.1990.69.5.1767 · Cited by 192
Vaz, M., Hwang, S. Y., Kagiampakis, I., Phallen, J., Patil, A., O'Hagan, H. M., Murphy, L., Zahnow, C. A., Gabrielson, E., Velculescu, V. E., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.006 · Cited by 191
Limeta, A., Ji, B., Levin, M., Gatto, F., & Nielsen, J. (2020) · JCI Insight · doi:10.1172/jci.insight.140940 · Cited by 185
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity
Bessell, C. A., Isser, A., Havel, J. J., Lee, S., Bell, D. R., Hickey, J. W., Chaisawangwong, W., Glick Bieler, J., Srivastava, R., Kuo, F., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135597 · Cited by 184
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer
Di Modica, M., Gargari, G., Regondi, V., Bonizzi, A., Arioli, S., Belmonte, B., De Cecco, L., Fasano, E., Bianchi, F., Bertolotti, A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1659 · Cited by 184 · cited 3×
“Genetic clonal evolution also fails to account for microbialmediated treatment efficacy or failure of (i) cyclophosphamide,[66,101] gemcitabine,[47] and platinum-based[67,102] chemotherapy; (ii) antiCTLA-4 and anti-PD-(L)1 ICB efficacy[12–14,96–100]; (iii) androgen deprivation therapy in prostate cancer[65]; and (iv)…”
BackgroundInfluentialClonal interference in large populations
Park, S.-C., & Krug, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705778104 · Cited by 179
Bacteria as vectors for gene therapy of cancer
Baban, C. K., Cronin, M., O’Hanlon, D., O’Sullivan, G. C., & Tangney, M. (2010) · Bioengineered Bugs · doi:10.4161/bbug.1.6.13146 · Cited by 175
Antibiotic collateral sensitivity is contingent on the repeatability of evolution
Nichol, D., Rutter, J., Bryant, C., Hujer, A. M., Lek, S., Adams, M. D., Jeavons, P., Anderson, A. R. A., Bonomo, R. A., & Scott, J. G. (2019) · Nature Communications · doi:10.1038/s41467-018-08098-6 · Cited by 174
Reconstructing metastatic seeding patterns of human cancers
Reiter, J. G., Makohon-Moore, A. P., Gerold, J. M., Bozic, I., Chatterjee, K., Iacobuzio-Donahue, C. A., Vogelstein, B., & Nowak, M. A. (2017) · Nature Communications · doi:10.1038/ncomms14114 · Cited by 170
Martin, G. S. (2004) · Oncogene · doi:10.1038/sj.onc.1208077 · Cited by 159
Archetti, M., Ferraro, D. A., & Christofori, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414653112 · Cited by 158
Nené, N. R., Reisel, D., Leimbach, A., Franchi, D., Jones, A., Evans, I., Knapp, S., Ryan, A., Ghazali, S., Timms, J. F., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30340-7 · Cited by 156
Clonal fitness inferred from time-series modelling of single-cell cancer genomes
Salehi, S., Kabeer, F., Ceglia, N., Andronescu, M., Williams, M. J., Campbell, K. R., Masud, T., Wang, B., Biele, J., Brimhall, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03648-3 · Cited by 152
The harsh microenvironment in early breast cancer selects for a Warburg phenotype
Damaghi, M., West, J., Robertson-Tessi, M., Xu, L., Ferrall-Fairbanks, M. C., Stewart, P. A., Persi, E., Fridley, B. L., Altrock, P. M., Gatenby, R. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011342118 · Cited by 142
Sims, T. T., El Alam, M. B., Karpinets, T. V., Dorta-Estremera, S., Hegde, V. L., Nookala, S., Yoshida-Court, K., Wu, X., Biegert, G. W. G., Delgado Medrano, A. Y., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01741-x · Cited by 135
metaGEM: reconstruction of genome scale metabolic models directly from metagenomes
Zorrilla, F., Buric, F., Patil, K. R., & Zelezniak, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab815 · Cited by 135
Fever and cancer in perspective
Hobohm, U. (2001) · Cancer Immunology Immunotherapy · doi:10.1007/s002620100216 · Cited by 133
Zomorrodi, A. R., & Segrè, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01407-5 · Cited by 130
Daisley, B. A., Chanyi, R. M., Abdur-Rashid, K., Al, K. F., Gibbons, S., Chmiel, J. A., Wilcox, H., Reid, G., Anderson, A., Dewar, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18649-5 · Cited by 128
Genome scale metabolic modeling of cancer
Nilsson, A., & Nielsen, J. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.10.022 · Cited by 127
Kordahi, M. C., Stanaway, I. B., Avril, M., Chac, D., Blanc, M.-P., Ross, B. D., Diener, C., Jain, S., McCleary, P., Parker, A., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.08.013 · Cited by 123
Gutierrez, C., Al’Khafaji, A. M., Brenner, E. A., Johnson, K. E., Gohil, S. H., Lin, Z., Knisbacher, B. A., Durrett, R., Li, S., Parvin, S., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00222-8 · Cited by 118
Towards Predictive Models of the Human Gut Microbiome
Bucci, V., & Xavier, J. B. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.03.017 · Cited by 113
Basanta, D., Scott, J. G., Fishman, M. N., Ayala, G., Hayward, S. W., & Anderson, A. R. A. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.517 · Cited by 113
Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome
Barrett, M., Hand, C. K., Shanahan, F., Murphy, T., & O’Toole, P. W. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.019 · Cited by 108 · cited 2×
“[139] Gut-residing Proteobacteria produce cytolethal distending toxin (CDT) that induces single- and doublestranded DNA breaks.[152] Collectively, these mechanisms shape can-”
BackgroundHow stands the Tree of Life a century and a half after The Origin?
O'Malley, M. A., & Koonin, E. V. (2011) · Biology Direct · doi:10.1186/1745-6150-6-32 · Cited by 106
Bacteria in gene therapy: bactofection versus alternative gene therapy
Pálffy, R., Gardlík, R., Hodosy, J., Behuliak, M., Resko, P., Radvánský, J., & Celec, P. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302635 · Cited by 103
Signatures of ecological processes in microbial community time series
Faust, K., Bauchinger, F., Laroche, B., de Buyl, S., Lahti, L., Washburne, A. D., Gonze, D., & Widder, S. (2018) · Microbiome · doi:10.1186/s40168-018-0496-2 · Cited by 100
Dobson, S. M., García-Prat, L., Vanner, R. J., Wintersinger, J., Waanders, E., Gu, Z., McLeod, J., Gan, O. I., Grandal, I., Payne-Turner, D., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1059 · Cited by 94
Shashni, B., Ariyasu, S., Takeda, R., Suzuki, T., Shiina, S., Akimoto, K., Maeda, T., Aikawa, N., Abe, R., Osaki, T., et al. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00776 · Cited by 93
Selective isolation of bacterial DNA from human clinical specimens
Horz, H., Scheer, S., Huenger, F., Vianna, M. E., & Conrads, G. (2007) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.10.007 · Cited by 88
Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions
Klein, C., Gonzalez, D., Samwel, K., Kahesa, C., Mwaiselage, J. D., Aluthge, N. D., Fernando, S. C., West, J. T., Wood, C. A., & Angeletti, P. C. (2019) · mBio · doi:10.1128/mbio.02785-18 · Cited by 83
Doulcier, G., Lambert, A., Monte, S. D., & Rainey, P. B. (2020) · eLife · doi:10.7554/elife.53433 · Cited by 78
Real-Time Selective Sequencing with RUBRIC: Read Until with Basecall and Reference-Informed Criteria
Edwards, H. S., Krishnakumar, R., Sinha, A., Bird, S. W., Patel, K. D., & Bartsch, M. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-47857-3 · Cited by 77
Kaznatcheev, A., Velde, R. V., Scott, J. G., & Basanta, D. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.5 · Cited by 72
Couto, N., Schuele, L., Raangs, E. C., Machado, M. P., Mendes, C. I., Jesus, T. F., Chlebowicz, M. A., Rosema, S., Ramirez, M., Carriço, J. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31873-w · Cited by 72 · cited 1×
“[123] Although challenges remain for commercial host depletion andmicrobial enrichment strategies,[119,131] advancementswould tremendously aid low-biomass, intratumoral and blood-based cancer microbiome characterization.”
BackgroundRedox traits characterize the organization of global microbial communities
Ramírez‐Flandes, S., González, B., & Ulloa, O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817554116 · Cited by 70 · cited 1×
“, redox, chemotactic, oxygen gradients)[73] outside tumors also govern them inside tumors.”
Backgroundvan der Ark, K. C. H., van Heck, R. G. A., dos Santos, V. A. P. M., Belzer, C., & de Vos, W. M. (2017) · Microbiome · doi:10.1186/s40168-017-0299-x · Cited by 68
Tango, C. N., Seo, S., Kwon, M., Lee, D.-O., Chang, H. K., & Kim, M. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-66607-4 · Cited by 68
Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia
Anandasabapathy, S., Jhamb, J., Davila, M. L., Wei, C., Morris, J. S., & Bresalier, R. S. (2007) · Cancer · doi:10.1002/cncr.22451 · Cited by 59 · cited 1×
“protective and pathogenic roles: protective against gastric cardia and esophageal adenocarcinoma[165,166] andpathogenic in noncardiac gastric cancer.”
BackgroundMicrofluidic-based isolation of bacteria from whole blood for sepsis diagnostics
Zelenin, S. M., Hansson, J., Ardabili, S., Ramachandraiah, H., Brismar, H., & Russom, A. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1734-8 · Cited by 57
Komorowski, A. S., & Pezo, R. C. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05472-w · Cited by 57
Bacterial transfer of large functional genomic DNA into human cells
Laner, A., Goussard, S., Ramalho, A. S., Schwarz, T., Amaral, M. D., Courvalin, P. M., Schindelhauer, D., & Grillot‐Courvalin, C. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302576 · Cited by 52
Gut microbiome identifies risk for colorectal polyps
Dadkhah, E., Sikaroodi, M., Korman, L. Y., Hardi, R., Baybick, J. H., Hanzel, D. K., Kuehn, G., Kuehn, T., & Gillevet, P. M. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000297 · Cited by 52
Butler, D. S. C., Cafaro, C., Putze, J., Wan, M. L. Y., Tran, T. H., Ambite, I., Ahmadi, S., Kjellström, S., Welinder, C., Chao, S. M., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00805-3 · Cited by 52
Bacteria and game theory: the rise and fall of cooperation in spatially heterogeneous environments
Lambert, G., Vyawahare, S., & Austin, R. H. (2014) · Interface Focus · doi:10.1098/rsfs.2014.0029 · Cited by 49
Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription
Pang, J., Nguyen, N., Luebeck, J., Ball, L., Finegersh, A., Ren, S., Nakagawa, T., Flagg, M., Sadat, S., Mischel, P. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2484 · Cited by 48
Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression
Frankenstein, Z., Basanta, D., Franco, O. E., Gao, Y., Javier, R., Strand, D. W., Lee, M., Hayward, S. W., Ayala, G., & Anderson, A. R. A. (2020) · Nature Ecology & Evolution · doi:10.1038/s41559-020-1157-y · Cited by 46
Research works printed but not linked: 3
- Busch W., 1868, Aus der Sitzung der medicinischen Section vom 13 November 1867, Berl Klin Wochenschr, 5, 137
- Fehleisen F., 1882, Ueber die Züchtung der Erysipelkokken auf künstlichem Nährboden und ihre Übertragbarkeit auf den Menschen, Deutsche Medizinische Wochenschrift, 8, 553
- Jourdain A., 2021, Évolution clonale: Qu'est‐ce qu'un clone. La Biologie Au Défi de L'histoire, Chapitre, 10, 167
Cited by
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Narunsky-Haziza, L., Sepich-Poore, G. D., Livyatan, I., Asraf, O., Martino, C., Nejman, D., Gavert, N., Stajich, J. E., Amit, G., González, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.005 · Cited by 538
Self-citationMelanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89
Self-citationThe evolutionary theory of cancer: challenges and potential solutions
Laplane, L., & Maley, C. C. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00734-2 · Cited by 105
“The heterogeneous and focal distribution of intracellular bacteria lead to the notion of ‘microbial intra-clonal diversity’ whereby different fitness of cancer cells of the same genetic clone is dependent on the presence of intracellular bacteria 201 .”
InfluentialSelf-citationPolymorphic microbes: a new emerging hallmark of cancer
Lythgoe, M. P., Mullish, B. H., Frampton, A. E., & Krell, J. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.08.004 · Cited by 53
Chen, F., Yang, J., Guo, Y., Su, D., Sheng, Y., & Wu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140995 · Cited by 45
“Recent studies have revealed that extra- or intracellular communities of microbes are metabolically active and immunoreactive (16).”
Background
Metadata
- Authors
- Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R.
- Affiliations
- University of California San Diego (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Knight, Rob
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 2022-03-06
- Volume
- 44
- Issue
- 5
- Pages
- e2100252-e2100252
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- PMC
- PMC10506734
- OpenAlex
- W4221014894
- Cited by
- 33
- References
- 222
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 9 · 2022: 3
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- BioEssays (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- European Commission (HORIZON2020)
- Centre National de la Recherche Scientifique
- National Institutes of Health (CA023100)
- National Cancer Institute (R01CA255206, CA023100, U24CA248454, F30CA243480, P30CA023100)
- National Institute of General Medical Sciences (T32GM008806)
- National Center for Complementary and Integrative Health (DP1AT010885)
- H2020 European Research Council (637647)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- tumor microbiome, clonal evolution, multispecies interactions, intratumoral bacteria, intracellular bacteria, metastasis, treatment resistance
- MeSH terms
- Biological Evolution, Humans, Neoplasms, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.